BACKGROUND: In recent years several endoscopic and video-assisted techniques for parathyroidectomy have been described. The role of these techniques, with respect to time-honored conventional surgery, has been largely debated. This paper was designed to review the evidence, and make the recommendations, for the video-assisted/endoscopic approach to parathyroidectomy. METHODS: A database search was conducted in PubMed from which abstracts were screened matching our definition. Publications were further assessed and assigned their respective level of evidence. Additional data were obtained on the basis of our personal experience. RESULTS: Thirty-eight mainly retrospective studies have been published. Only four small, prospective, randomized trials, providing level II evidence, and one retrospective case-control comparative study, providing level IV evidence, have been found. Minimally invasive video-assisted parathyroidectomy (MIVAP) has emerged as one of the leading techniques. To date several randomized studies have shown that MIVAP is an efficacious and feasible procedure with the same complications rate as conventional surgery. Moreover, MIVAP seems to have significant advantages in terms of cosmetic result, postoperative pain and recovery, and patient satisfaction. CONCLUSIONS: From an evidence-based point of view, MIVAP should be considered a valid and validated option for the treatment of sporadic primary hyperparathyroidism sustained by a well-localized, single adenoma. Its role for the treatment of multiglandular diseases (familial hyperparathyroidism, secondary hyperparathyroidism) needs to be better clarified.
BACKGROUND: In recent years several endoscopic and video-assisted techniques for parathyroidectomy have been described. The role of these techniques, with respect to time-honored conventional surgery, has been largely debated. This paper was designed to review the evidence, and make the recommendations, for the video-assisted/endoscopic approach to parathyroidectomy. METHODS: A database search was conducted in PubMed from which abstracts were screened matching our definition. Publications were further assessed and assigned their respective level of evidence. Additional data were obtained on the basis of our personal experience. RESULTS: Thirty-eight mainly retrospective studies have been published. Only four small, prospective, randomized trials, providing level II evidence, and one retrospective case-control comparative study, providing level IV evidence, have been found. Minimally invasive video-assisted parathyroidectomy (MIVAP) has emerged as one of the leading techniques. To date several randomized studies have shown that MIVAP is an efficacious and feasible procedure with the same complications rate as conventional surgery. Moreover, MIVAP seems to have significant advantages in terms of cosmetic result, postoperative pain and recovery, and patient satisfaction. CONCLUSIONS: From an evidence-based point of view, MIVAP should be considered a valid and validated option for the treatment of sporadic primary hyperparathyroidism sustained by a well-localized, single adenoma. Its role for the treatment of multiglandular diseases (familial hyperparathyroidism, secondary hyperparathyroidism) needs to be better clarified.
Authors: Christina Lenschow; Peter Gassmann; Christian Wenning; Norbert Senninger; Mario Colombo-Benkmann Journal: World J Surg Date: 2015-07 Impact factor: 3.352
Authors: L Rosato; M Raffaelli; R Bellantone; A Pontecorvi; N Avenia; M Boniardi; M L Brandi; F Cetani; M G Chiofalo; G Conzo; M De Palma; G Gasparri; A Giordano; N Innaro; E Leopaldi; G Mariani; C Marcocci; P Marini; P Miccoli; P Nasi; F Pacini; R Paragliola; M R Pelizzo; M Testini; G De Toma Journal: J Endocrinol Invest Date: 2014-01-09 Impact factor: 4.256
Authors: Pier Francesco Alesina; Jakob Hinrichs; Matthias Heuer; Sebastian Hofmeister; Beate Meier; Martin K Walz Journal: Langenbecks Arch Surg Date: 2012-11-25 Impact factor: 3.445
Authors: Paolo Del Rio; Diego Vicente; Umberto Maestroni; Anna Totaro; Gian Maria Casoni Pattacini; Itzhak Avital; Alexander Stojadinovic; Mario Sianesi Journal: J Cancer Date: 2013-07-03 Impact factor: 4.207